Age 0 3 0 3 B-age
≥ 4 5 4 5 O
3 6 7 6 7 B-lower_bound
years 8 13 8 13 I-lower_bound

Available 0 9 14 23 O
autologous 10 20 24 34 B-clinical_variable
transduced 21 31 35 45 I-clinical_variable
T 32 33 46 47 I-clinical_variable
lymphocytes 34 45 48 59 I-clinical_variable
with 46 50 60 64 O
greater 51 58 65 72 O
than 59 63 73 77 O
or 64 66 78 80 O
equal 67 72 81 86 O
to 73 75 87 89 O
15 76 78 90 92 B-lower_bound
% 78 79 92 93 I-lower_bound
expression 80 90 94 104 O
of 91 93 105 107 O
HER2 94 98 108 112 B-clinical_variable
CAR 99 102 113 116 O
determined 103 113 117 127 O
by 114 116 128 130 O
flow 117 121 131 135 O
- 121 122 135 136 O
cytometry 122 131 136 145 O
and 132 135 146 149 O
killing 136 143 150 157 O
of 144 146 158 160 O
HER2 147 151 161 165 O
- 151 152 165 166 O
positive 152 160 166 174 O
targets 161 168 175 182 O
greater 169 176 183 190 O
than 177 181 191 195 O
or 182 184 196 198 O
equal 185 190 199 204 O
to 191 193 205 207 O
20 194 196 208 210 B-lower_bound
% 196 197 210 211 I-lower_bound
in 198 200 212 214 O
cytotoxicity 201 213 215 227 B-treatment
assay 214 219 228 233 I-treatment

Bilirubin 0 9 234 243 B-clinical_variable
less 10 14 244 248 O
than 15 19 249 253 O
or 20 22 254 256 O
equal 23 28 257 262 O
to 29 31 263 265 O
3x 32 34 266 268 B-upper_bound
normal 35 41 269 275 I-upper_bound
, 41 42 275 276 O
AST 43 46 277 280 B-clinical_variable
less 47 51 281 285 O
than 52 56 286 290 O
or 57 59 291 293 O
equal 60 65 294 299 O
to 66 68 300 302 O
5x 69 71 303 305 B-upper_bound
normal 72 78 306 312 I-upper_bound
, 78 79 312 313 O
ALT 80 83 314 317 B-clinical_variable
less 84 88 318 322 O
than 89 93 323 327 O
or 94 96 328 330 O
equal 97 102 331 336 O
to 103 105 337 339 O
5x 106 108 340 342 O
, 108 109 342 343 O
serum 110 115 344 349 B-clinical_variable
creatinine 116 126 350 360 I-clinical_variable
less 127 131 361 365 O
than 132 136 366 370 O
or 137 139 371 373 O
equal 140 145 374 379 O
to 146 148 380 382 O
2x 149 151 383 385 B-upper_bound
upper 152 157 386 391 I-upper_bound
limit 158 163 392 397 I-upper_bound
of 164 166 398 400 I-upper_bound
normal 167 173 401 407 I-upper_bound
for 174 177 408 411 O
age 178 181 412 415 B-age
, 181 182 415 416 O
and 183 186 417 420 O
Hgb 187 190 421 424 B-clinical_variable
greater 191 198 425 432 O
than 199 203 433 437 O
or 204 206 438 440 O
equal 207 212 441 446 O
to 213 215 447 449 O
7.0 216 219 450 453 B-upper_bound

Dexamethasone 0 13 454 467 B-treatment
up 14 16 468 470 O
to 17 19 471 473 O
a 20 21 474 475 O
total 22 27 476 481 O
dose 28 32 482 486 O
of 33 35 487 489 O
2 36 37 490 491 B-upper_bound
mg 38 40 492 494 I-upper_bound
per 41 44 495 498 I-upper_bound
day 45 48 499 502 I-upper_bound
will 49 53 503 507 O
be 54 56 508 510 O
allowed 57 64 511 518 O
if 65 67 519 521 O
medically 68 77 522 531 O
indicated 78 87 532 541 O

Diagnosis 0 9 542 551 O
of 10 12 552 554 O
DIPG 13 17 555 559 B-cancer

HER2 0 4 560 564 O
expression 5 15 565 575 O
in 16 18 576 578 O
tumors 19 25 579 585 B-cancer
on 26 28 586 588 O
IHC 29 32 589 592 B-clinical_variable
should 33 39 593 599 O
be 40 42 600 602 O
greater 43 50 603 610 O
than 51 55 611 615 O
or 56 58 616 618 O
equal 59 64 619 624 O
to 65 67 625 627 O
grade 68 73 628 633 B-lower_bound
1 74 75 634 635 I-lower_bound
and 76 79 636 639 O
greater 80 87 640 647 O
than 88 92 648 652 O
or 93 95 653 655 O
equal 96 101 656 661 O
to 102 104 662 664 O
1 105 106 665 666 O
+ 106 107 666 667 O
intensity 108 117 668 677 B-clinical_variable
score 118 123 678 683 I-clinical_variable

History 0 7 684 691 O
of 8 10 692 694 O
hypersensitivity 11 27 695 711 O
reactions 28 37 712 721 O
to 38 40 722 724 O
murine 41 47 725 731 B-allergy_name
protein 48 55 732 739 I-allergy_name
- 55 56 739 740 I-allergy_name
containing 56 66 740 750 I-allergy_name
products 67 75 751 759 I-allergy_name

Immunohistochemistry 0 20 760 780 B-treatment
( 21 22 781 782 I-treatment
IHC 22 25 782 785 I-treatment
) 25 26 785 786 I-treatment
or 27 29 787 789 O
RT 30 32 790 792 B-treatment
- 32 33 792 793 I-treatment
PCR 33 36 793 796 I-treatment
will 37 41 797 801 O
be 42 44 802 804 O
used 45 49 805 809 O
to 50 52 810 812 O
determine 53 62 813 822 O
HER2 63 67 823 827 O
positivity 68 78 828 838 O
. 78 79 838 839 O
Results 80 87 840 847 O
will 88 92 848 852 O
be 93 95 853 855 O
compared 96 104 856 864 O
to 105 107 865 867 O
standard 108 116 868 876 O
controls 117 125 877 885 O

Karnofsky 0 9 886 895 B-clinical_variable
/ 9 10 895 896 O
Lansky 10 16 896 902 B-clinical_variable
score 17 22 903 908 I-clinical_variable
of 23 25 909 911 O
greater 26 33 912 919 O
than 34 38 920 924 O
or 39 41 925 927 O
equal 42 47 928 933 O
to 48 50 934 936 O
60 51 53 937 939 B-lower_bound

Karnofsky 0 9 940 949 B-clinical_variable
/ 9 10 949 950 I-clinical_variable
Lansky 10 16 950 956 I-clinical_variable
score 17 22 957 962 I-clinical_variable
≥ 23 24 963 964 O
60 25 27 965 967 B-lower_bound

Known 0 5 968 973 O
HIV 6 9 974 977 B-chronic_disease
positivity 10 20 978 988 O

Life 0 4 989 993 B-clinical_variable
expectancy 5 15 994 1004 I-clinical_variable
≥ 16 17 1005 1006 O
6 18 19 1007 1008 B-lower_bound
weeks 20 25 1009 1014 I-lower_bound

Pregnant 0 8 1015 1023 B-pregnancy
or 9 11 1024 1026 O
lactating 12 21 1027 1036 O

Pulse 0 5 1037 1042 B-clinical_variable
oximetry 6 14 1043 1051 I-clinical_variable
of 15 17 1052 1054 O
greater 18 25 1055 1062 O
than 26 30 1063 1067 O
or 31 33 1068 1070 O
equal 34 39 1071 1076 O
to 40 42 1077 1079 O
90 43 45 1080 1082 B-lower_bound
% 45 46 1082 1083 I-lower_bound
on 47 49 1084 1086 O
room 50 54 1087 1091 O
air 55 58 1092 1095 O

Recurrent 0 9 1096 1105 O
or 10 12 1106 1108 O
refractory 13 23 1109 1119 O
HER2 24 28 1120 1124 B-cancer
positive 29 37 1125 1133 I-cancer
primary 38 45 1134 1141 I-cancer
central 46 53 1142 1149 I-cancer
nervous 54 61 1150 1157 I-cancer
system 62 68 1158 1164 I-cancer
( 69 70 1165 1166 I-cancer
CNS 70 73 1166 1169 I-cancer
) 73 74 1169 1170 I-cancer
tumor 75 80 1171 1176 I-cancer
or 81 83 1177 1179 O
HER2 84 88 1180 1184 B-cancer
positive 89 97 1185 1193 I-cancer
tumor 98 103 1194 1199 I-cancer
metastatic 104 114 1200 1210 I-cancer
to 115 117 1211 1213 O
the 118 121 1214 1217 O
CNS 122 125 1218 1221 O

Recurrent 0 9 1222 1231 O
or 10 12 1232 1234 O
refractory 13 23 1235 1245 O
HER2 24 28 1246 1250 B-cancer
- 28 29 1250 1251 I-cancer
positive 29 37 1251 1259 I-cancer

Severe 0 6 1260 1266 O
intercurrent 7 19 1267 1279 B-chronic_disease
infection 20 29 1280 1289 I-chronic_disease

Sexually 0 8 1290 1298 O
active 9 15 1299 1305 O
subjects 16 24 1306 1314 O
must 25 29 1315 1319 O
be 30 32 1320 1322 O
willing 33 40 1323 1330 O
to 41 43 1331 1333 O
utilize 44 51 1334 1341 O
one 52 55 1342 1345 B-lower_bound
of 56 58 1346 1348 O
the 59 62 1349 1352 O
more 63 67 1353 1357 O
effective 68 77 1358 1367 O
birth 78 83 1368 1373 O
control 84 91 1374 1381 O
methods 92 99 1382 1389 O
for 100 103 1390 1393 O
6 104 105 1394 1395 O
months 106 112 1396 1402 O
after 113 118 1403 1408 O
the 119 122 1409 1412 O
T 123 124 1413 1414 B-treatment
cell 125 129 1415 1419 I-treatment
infusion 130 138 1420 1428 I-treatment

Steroid 0 7 1429 1436 O
dose 8 12 1437 1441 O
of 13 15 1442 1444 O
dexamethasone 16 29 1445 1458 B-treatment
greater 30 37 1459 1466 O
than 38 42 1467 1471 O
2 43 44 1472 1473 B-lower_bound
mg 45 47 1474 1476 I-lower_bound
per 48 51 1477 1480 O
day 52 55 1481 1484 O
( 56 57 1485 1486 O
or 57 59 1486 1488 O
equivalent 60 70 1489 1499 O
) 70 71 1499 1500 O

Subjects 0 8 1501 1509 O
having 9 15 1510 1516 O
a 16 17 1517 1518 O
tumor 18 23 1519 1524 B-treatment
resection 24 33 1525 1534 I-treatment
if 34 36 1535 1537 O
medically 37 46 1538 1547 O
feasible 47 55 1548 1556 O

Subjects 0 8 1557 1565 O
should 9 15 1566 1572 O
have 16 20 1573 1577 O
been 21 25 1578 1582 O
off 26 29 1583 1586 O
other 30 35 1587 1592 O
investigational 36 51 1593 1608 O
antineoplastic 52 66 1609 1623 B-treatment
therapy 67 74 1624 1631 I-treatment
for 75 78 1632 1635 O
two 79 82 1636 1639 B-upper_bound
weeks 83 88 1640 1645 I-upper_bound
prior 89 94 1646 1651 I-upper_bound
to 95 97 1652 1654 O
entry 98 103 1655 1660 O
in 104 106 1661 1663 O
this 107 111 1664 1668 O
study 112 117 1669 1674 O

Temozolomide 0 12 1675 1687 B-treatment
will 13 17 1688 1692 O
be 18 20 1693 1695 O
allowed 21 28 1696 1703 O
up 29 31 1704 1706 O
to 32 34 1707 1709 O
48 35 37 1710 1712 B-upper_bound
hours 38 43 1713 1718 I-upper_bound
preinfusion 44 55 1719 1730 O

The 0 3 1731 1734 O
male 4 8 1735 1739 B-gender
partner 9 16 1740 1747 O
should 17 23 1748 1754 O
use 24 27 1755 1758 O
a 28 29 1759 1760 O
condom 30 36 1761 1767 O

Wherein 0 7 1768 1775 O
grades 8 14 1776 1782 O
are 15 18 1783 1786 O
defines 19 26 1787 1794 O
as 27 29 1795 1797 O
: 29 30 1797 1798 O
Grade 31 36 1799 1804 O
0 37 38 1805 1806 O
: 38 39 1806 1807 O
no 40 42 1808 1810 O
staining 43 51 1811 1819 O
; 51 52 1819 1820 O
Grade 53 58 1821 1826 O
1 59 60 1827 1828 B-lower_bound
: 60 61 1828 1829 O
1 62 63 1830 1831 O
- 63 64 1831 1832 O
25 64 66 1832 1834 B-upper_bound
% 66 67 1834 1835 I-upper_bound
; 67 68 1835 1836 O
Grade 69 74 1837 1842 O
2 75 76 1843 1844 O
: 76 77 1844 1845 O
26 78 80 1846 1848 B-lower_bound
- 80 81 1848 1849 O
50 81 83 1849 1851 B-upper_bound
% 83 84 1851 1852 I-upper_bound
and 85 88 1853 1856 O
Grade 89 94 1857 1862 O
3 95 96 1863 1864 O
: 96 97 1864 1865 O
51 98 100 1866 1868 B-lower_bound
- 100 101 1868 1869 O
100 101 104 1869 1872 B-upper_bound
% 104 105 1872 1873 I-upper_bound
of 106 108 1874 1876 O
cell 109 113 1877 1881 O
staining 114 122 1882 1890 O
for 123 126 1891 1894 O
HER2 127 131 1895 1899 B-cancer
and 132 135 1900 1903 O
intensity 136 145 1904 1913 O
scores 146 152 1914 1920 O
are 153 156 1921 1924 O
: 156 157 1924 1925 O
negative 158 166 1926 1934 O
; 166 167 1934 1935 O
1 168 169 1936 1937 O
+ 169 170 1937 1938 O
; 170 171 1938 1939 O
2 172 173 1940 1941 O
+ 173 174 1941 1942 O
and 175 178 1943 1946 O
3 179 180 1947 1948 O
+ 180 181 1948 1949 O
using 182 187 1950 1955 O
breast 188 194 1956 1962 B-treatment
cancer 195 201 1963 1969 I-treatment
standard 202 210 1970 1978 I-treatment
arrays 211 217 1979 1985 I-treatment
as 218 220 1986 1988 O
a 221 222 1989 1990 O
guide 223 228 1991 1996 O
for 229 232 1997 2000 O
intensity 233 242 2001 2010 O

primary 0 7 2011 2018 B-cancer
CNS 8 11 2019 2022 I-cancer
tumor 12 17 2023 2028 I-cancer
or 18 20 2029 2031 O
HER2 21 25 2032 2036 B-cancer
- 25 26 2036 2037 I-cancer
positive 26 34 2037 2045 I-cancer
solid 35 40 2046 2051 I-cancer
tumor 41 46 2052 2057 I-cancer
metastatic 47 57 2058 2068 I-cancer
to 58 60 2069 2071 O
the 61 64 2072 2075 O
CNS 65 68 2076 2079 O

